We found positive staining for PRMT6 in 23.7% of CRC samples (139 of 586 patients) (Table 1 and Supplementary Table 2), and the enzyme was localized exclusively in the nucleus (Figure 2A and Supplementary Figure 1). This evidence concerns the gene PRMT6 and colorectal carcinoma.